Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial

Clinical trial NCT06812637 · COMPLETED

Trial details

NCT number: NCT06812637
Sponsor: Kafrelsheikh University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Foot Ulcer (DFU)Exosomes

Start date: 2024-04-06
Primary completion: 2024-06-06
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.